The effect of HAART on humoral immune response in primary HIV-1 infected patients

Claudia Pastori, C. Barassi, F. Lillo, R. Longhi, B. Capiluppi, S. Nozza, A. Galli, C. Uberti-Foppa, A. Lazzarin, G. Tambussi, L. Lopalco

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The effect of Highly Active Antiretroviral Therapy (HAART) on binding and neutralizing antibody responses to human immunodeficiency virus type-1 (HIV-1) during primary and chronic infection was investigated. Seven patients HAART treated during primary infection, six HAART treated during chronic infection and five patients treated only with ZVD (Zidovudine) were analysed. HAART inhibited the development of anti env antibodies during primary infection. Administering HAART during primary infection usually did not substantially affect the development of weak neutralizing antibody responses against autologous virus. However, we demonstrated that very early treatment, during seroconversion, induce in some cases, a strong neutralizing antibodies against autologous virus. These results may be relevant for understanding how HAART may elicit a strong protective responses and may be useful in developing new strategies designed to achieve a long term control of the HIV infection.

Original languageEnglish
Pages (from-to)9-17
Number of pages9
JournalJournal of Biological Regulators and Homeostatic Agents
Volume16
Issue number1
Publication statusPublished - 2002

Fingerprint

Highly Active Antiretroviral Therapy
Humoral Immunity
Human immunodeficiency virus 1
humoral immunity
HIV-1
therapeutics
Neutralizing Antibodies
neutralizing antibodies
Infection
infection
Antibody Formation
Viruses
viruses
Zidovudine
HIV infections
seroconversion
HIV Infections
Anti-Idiotypic Antibodies
antibodies

Keywords

  • HAART
  • HIV-1
  • Humoral immunity
  • Neutralizing antibodies
  • PHI

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Endocrinology
  • Physiology
  • Immunology
  • Medicine (miscellaneous)
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)

Cite this

The effect of HAART on humoral immune response in primary HIV-1 infected patients. / Pastori, Claudia; Barassi, C.; Lillo, F.; Longhi, R.; Capiluppi, B.; Nozza, S.; Galli, A.; Uberti-Foppa, C.; Lazzarin, A.; Tambussi, G.; Lopalco, L.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 16, No. 1, 2002, p. 9-17.

Research output: Contribution to journalArticle

@article{e3c58c5b8be9495cb782637bb9448941,
title = "The effect of HAART on humoral immune response in primary HIV-1 infected patients",
abstract = "The effect of Highly Active Antiretroviral Therapy (HAART) on binding and neutralizing antibody responses to human immunodeficiency virus type-1 (HIV-1) during primary and chronic infection was investigated. Seven patients HAART treated during primary infection, six HAART treated during chronic infection and five patients treated only with ZVD (Zidovudine) were analysed. HAART inhibited the development of anti env antibodies during primary infection. Administering HAART during primary infection usually did not substantially affect the development of weak neutralizing antibody responses against autologous virus. However, we demonstrated that very early treatment, during seroconversion, induce in some cases, a strong neutralizing antibodies against autologous virus. These results may be relevant for understanding how HAART may elicit a strong protective responses and may be useful in developing new strategies designed to achieve a long term control of the HIV infection.",
keywords = "HAART, HIV-1, Humoral immunity, Neutralizing antibodies, PHI",
author = "Claudia Pastori and C. Barassi and F. Lillo and R. Longhi and B. Capiluppi and S. Nozza and A. Galli and C. Uberti-Foppa and A. Lazzarin and G. Tambussi and L. Lopalco",
year = "2002",
language = "English",
volume = "16",
pages = "9--17",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "1",

}

TY - JOUR

T1 - The effect of HAART on humoral immune response in primary HIV-1 infected patients

AU - Pastori, Claudia

AU - Barassi, C.

AU - Lillo, F.

AU - Longhi, R.

AU - Capiluppi, B.

AU - Nozza, S.

AU - Galli, A.

AU - Uberti-Foppa, C.

AU - Lazzarin, A.

AU - Tambussi, G.

AU - Lopalco, L.

PY - 2002

Y1 - 2002

N2 - The effect of Highly Active Antiretroviral Therapy (HAART) on binding and neutralizing antibody responses to human immunodeficiency virus type-1 (HIV-1) during primary and chronic infection was investigated. Seven patients HAART treated during primary infection, six HAART treated during chronic infection and five patients treated only with ZVD (Zidovudine) were analysed. HAART inhibited the development of anti env antibodies during primary infection. Administering HAART during primary infection usually did not substantially affect the development of weak neutralizing antibody responses against autologous virus. However, we demonstrated that very early treatment, during seroconversion, induce in some cases, a strong neutralizing antibodies against autologous virus. These results may be relevant for understanding how HAART may elicit a strong protective responses and may be useful in developing new strategies designed to achieve a long term control of the HIV infection.

AB - The effect of Highly Active Antiretroviral Therapy (HAART) on binding and neutralizing antibody responses to human immunodeficiency virus type-1 (HIV-1) during primary and chronic infection was investigated. Seven patients HAART treated during primary infection, six HAART treated during chronic infection and five patients treated only with ZVD (Zidovudine) were analysed. HAART inhibited the development of anti env antibodies during primary infection. Administering HAART during primary infection usually did not substantially affect the development of weak neutralizing antibody responses against autologous virus. However, we demonstrated that very early treatment, during seroconversion, induce in some cases, a strong neutralizing antibodies against autologous virus. These results may be relevant for understanding how HAART may elicit a strong protective responses and may be useful in developing new strategies designed to achieve a long term control of the HIV infection.

KW - HAART

KW - HIV-1

KW - Humoral immunity

KW - Neutralizing antibodies

KW - PHI

UR - http://www.scopus.com/inward/record.url?scp=0036245129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036245129&partnerID=8YFLogxK

M3 - Article

C2 - 12003182

AN - SCOPUS:0036245129

VL - 16

SP - 9

EP - 17

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 1

ER -